Overlapping of different degenerative diseases is a frequent phenomenon, for example, in patients with Alzheimer’s disease (AD), where around 50–60% of sporadic and genetic patients, carrying pathogenic mutations in APP, PSEN1, or PSEN2 genes, manifest widespread α-synuclein pathology [9,10]. Here, SNCA is linked to neurodegenerative disease.